Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion evidence source_evidence_literature NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion SIO_000772 14614893 NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion wasDerivedFrom befree-20150227 NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion wasGeneratedBy ECO_0000203 NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.